Literature DB >> 32914645

The Metabolomic Underpinnings of Symptom Burden in Patients With Multiple Chronic Conditions.

Elizabeth J Corwin1, Glenna Brewster2, Sandra B Dunbar2, Jessica Wells2, Vicki Hertzberg2, Marcia Holstad2, Mi-Kyung Song2, Dean Jones3.   

Abstract

Over 25% of the adult population in the United States suffers from multiple chronic conditions, with numbers continuing to rise. Those with multiple chronic conditions often experience symptoms or symptom clusters that undermine their quality of life and ability to self-manage. Importantly, symptom severity in those with even the same multiple chronic conditions varies, suggesting that the mechanisms driving symptoms in patients with multiple chronic conditions are not fixed but may differ in ways that could make them amenable to targeted interventions. In this manuscript we describe at a metabolic level, the symptom experience of persons with multiple chronic conditions, including how symptoms may synergize or cluster across multiple chronic conditions to augment one's symptom burden. To guide this discussion, we consider the metabolites and metabolic pathways known to span multiple adverse health conditions and associate with severe symptoms of fatigue, depression, and anxiety and their cluster. We also describe how severe versus mild symptoms, and their associated metabolites and metabolic pathways, may vary, depending on the presence of covariates; two of which, sex as a biological variable and the contribution of gut microbiota dysbiosis, are discussed in additional detail. Intertwining metabolomics and symptom science into nursing research, offers the unique opportunity to better understand how the metabolites and metabolic pathways affected in those with multiple chronic conditions may initiate or exacerbate symptom presence within a given individual, ultimately allowing clinicians to develop targeted interventions to improve the health quality of patients their families.

Entities:  

Keywords:  metablomics; multiple chronic conditions; sickness behavior; symptom science

Mesh:

Year:  2020        PMID: 32914645      PMCID: PMC8264861          DOI: 10.1177/1099800420958196

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  105 in total

1.  Multiple chronic conditions among adults aged 45 and over: trends over the past 10 years.

Authors:  Virginia M Freid; Amy B Bernstein; Mary Ann Bush
Journal:  NCHS Data Brief       Date:  2012-07

Review 2.  The role of inflammation in depression: from evolutionary imperative to modern treatment target.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

3.  Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation.

Authors:  M Lyte; J J Varcoe; M T Bailey
Journal:  Physiol Behav       Date:  1998-08

Review 4.  Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer.

Authors:  Jonathan P Godbout; Ronald Glaser
Journal:  J Neuroimmune Pharmacol       Date:  2006-08-10       Impact factor: 4.147

Review 5.  Sex differences in anxiety and depression clinical perspectives.

Authors:  Margaret Altemus; Nilofar Sarvaiya; C Neill Epperson
Journal:  Front Neuroendocrinol       Date:  2014-06-02       Impact factor: 8.606

Review 6.  Evolutionary medicine and chronic inflammatory state--known and new concepts in pathophysiology.

Authors:  Rainer H Straub
Journal:  J Mol Med (Berl)       Date:  2012-01-22       Impact factor: 4.599

7.  The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.

Authors:  Gerwyn Morris; Michael Berk
Journal:  BMC Med       Date:  2015-04-01       Impact factor: 8.775

Review 8.  Biomarkers of peripheral muscle fatigue during exercise.

Authors:  Josef Finsterer
Journal:  BMC Musculoskelet Disord       Date:  2012-11-08       Impact factor: 2.362

9.  Aggravation of Alzheimer's disease due to the COX-2-mediated reciprocal regulation of IL-1β and Aβ between glial and neuron cells.

Authors:  Pu Wang; Pei-Pei Guan; Tao Wang; Xin Yu; Jian-Jun Guo; Zhan-You Wang
Journal:  Aging Cell       Date:  2014-03-13       Impact factor: 9.304

Review 10.  Multimorbidity in chronic disease: impact on health care resources and costs.

Authors:  Steven M McPhail
Journal:  Risk Manag Healthc Policy       Date:  2016-07-05
View more
  5 in total

1.  Adaptation of Metabolomics and Microbiomic Research Protocols During the COVID-19 Pandemic.

Authors:  Brittany Butts; Taqiyya Alford; Glenna Brewster; Nicole Carlson; Ebony Coleman; Erica Davis; Erin Ferranti; Laura P Kimble; Laren Narapareddy; Jessica Wells; Irene Yang
Journal:  Nurs Res       Date:  2022 Mar-Apr 01       Impact factor: 2.381

2.  Proceedings of the Summer Institute on Symptoms and Omics.

Authors:  Irene Yang; Marcia Holstad
Journal:  Biol Res Nurs       Date:  2021-11-06       Impact factor: 2.522

3.  Symptom clusters in chronic kidney disease and their association with people's ability to perform usual activities.

Authors:  Currie Moore; Shalini Santhakumaran; Glen P Martin; Thomas J Wilkinson; Fergus J Caskey; Winnie Magadi; Rachel Gair; Alice C Smith; David Wellsted; Sabine N van der Veer
Journal:  PLoS One       Date:  2022-03-02       Impact factor: 3.240

4.  Innovations in Prospective Perinatal Research as a Result Of the COVID-19 Pandemic.

Authors:  Katherine Kissler; Rachel Blankstein Breman; Nicole Carlson; Ellen Tilden; Elise Erickson; Julia Phillippi
Journal:  J Midwifery Womens Health       Date:  2022-02-15       Impact factor: 2.891

5.  Acceptability and feasibility of fecal microBIOME and serum metabolite sample collection in people with end-stage kidney disease and pain being treated with HemoDialysis: A pilot study (BIOME-HDp).

Authors:  Mark B Lockwood; Michael J Fischer; Kimberly Silva; Blanca N Contreras; Guillermo Zamora; Amanda Goldstein; Monya Meinel; Christopher Holden; James Lash; Alana Steffens; Ardith Doorenbos
Journal:  Contemp Clin Trials Commun       Date:  2022-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.